Pharma Pulse 8/16/24: The Future of Launch Excellence is GenAI, Will Negotiated Drug Prices Actually Save Money? & more
The latest news for pharma industry insiders.
The Future of Launch Excellence is Generative AI
How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Questions Remain about Whether Negotiated Drug Prices will Save Money
The Medicare program is expected to see some aggregate savings from the negotiated drug prices. Beneficiaries, because of out-of-pocket caps next year, may not see the benefit, that is until the next round or two of negotiations if CMS choses drugs that are not heavily rebated.
US Drug Price Measure to Cut Costs by $7.5 Billion in 2026
The US government’s landmark drug price negotiations will save Americans $7.5 billion in its inaugural year, the Biden administration said, a first step toward driving down its world-leading pharmaceutical bill.
Rx Save Card Secures $1.7M in Pre-Seed Funding to Create Revolutionary Pharmacy Benefit Product
Rx Save Card, an innovative pharmacy benefit solution that allows employers and their employees to integrate an array of cost containment strategies into one integrated navigation and payment experience, announced the successful completion of their $1.7M seed funding round led by Distributed Ventures and participation from industry insiders.
Excited to be heading down to Washington, DC in a week and half for HDA - Healthcare Distribution Alliance's Traceability Seminar! It brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones - one of Pharmaceutical Commerce Magazine's bread and butters - so it should be a thought-provoking event.
I'll be covering sessions and will be conducting video interviews, so if that sounds of interest to you, let's connect!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
